当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:118.47亿  总市值:118.47亿
流通股本:3.18亿   总股本:3.18亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.42亿元,每股收益0.44元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益455649.71万元,未分配利润199373.31万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产568683.56万元,负债113033.85万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入686,909,061.522,280,896,019.231,826,339,651.431,270,455,870.9
营业总成本538,737,974.71,966,937,346.461,528,552,037.641,034,950,299.72
营业利润154,276,662.98438,401,339.39395,179,711.38312,024,833.1
利润总额154,701,391.69434,491,209.43391,622,464.17307,265,104.31
净利润141,852,238.97412,058,658.76365,645,845.17284,211,629.04
其他综合收益12,754.54-43,521,492.11-30,515,814.23-29,978,428.73
综合收益总额141,864,993.51368,537,166.65335,130,030.94254,233,200.31
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,748,960,813.132,536,028,043.522,636,531,294.082,893,908,129.69
非流动资产合计2,937,874,816.022,989,654,525.152,855,835,677.942,595,513,915.32
资产总计5,686,835,629.155,525,682,568.675,492,366,972.025,489,422,045.01
流动负债合计987,889,894.8941,663,492.8916,478,213.35993,177,820.34
非流动负债合计142,448,597.74144,056,077.15158,545,718.83160,373,499.2
负债合计1,130,338,492.541,085,719,569.951,075,023,932.181,153,551,319.54
归属于母公司股东权益合计4,342,842,117.064,230,710,929.54,207,513,559.884,128,038,704.49
股东权益合计4,556,497,136.614,439,962,998.724,417,343,039.844,335,870,725.47
负债和股东权益合计5,686,835,629.155,525,682,568.675,492,366,972.025,489,422,045.01
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计560,317,919.652,434,712,610.551,815,303,786.831,230,823,379.21
经营活动现金流出小计483,112,922.832,185,448,075.961,647,807,501.61,117,243,217.79
经营活动产生的现金流量净额77,204,996.82249,264,534.59167,496,285.23113,580,161.42
投资活动现金流入小计384,384,067.115,579,852,006.134,714,330,619.043,217,731,811.24
投资活动现金流出小计391,913,472.065,327,095,930.884,361,360,720.013,162,387,397.1
投资活动产生的现金流量净额-7,529,404.95252,756,075.25352,969,899.0355,344,414.14
筹资活动现金流入小计5,170,00011,895,0008,395,0006,395,000
筹资活动现金流出小计25,666,108.43180,194,490.64177,498,644.4171,273,569.73
筹资活动产生的现金流量净额-20,496,108.43-168,299,490.64-169,103,644.4-164,878,569.73
汇率变动对现金及现金等价物的影响1,245,666.7-8,238,268.42-6,078,181.47-2,297,481.26
现金及现金等价物净增加额50,425,150.14325,482,850.78345,284,358.391,748,524.57
期末现金及现金等价物余额1,307,071,714.341,256,646,564.21,276,448,071.81932,912,237.99
最新报告期:2024-04-30
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华创证券郑辰,李婵娟1.561.932.352024-04-30
东吴证券朱国广1.802.212.682024-04-29
华西证券王睿,崔文亮1.652.112.662024-04-28
浙商证券孙建1.882.312.812024-04-25
兴业证券东楠,孙媛媛,黄翰漾1.642.092.622024-04-11
TOP↑